Table 3 Standardized Mortality Ratios for various causes by year in trial.
Year of Study | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | Overall |
|---|---|---|---|---|---|---|---|---|---|
Women years | 188926 | 188467 | 187776 | 183826 | 146094 | 99763 | 46820 | 8057 | 1049731 |
Overall | 18.5% | 34.5% | 37.9% | 39.4% | 43.0% | 45.3% | 48.6% | 49.0% | 37.3% |
Cancers Overall | 19.7% | 49.7% | 61.3% | 59.9% | 70.4% | 74.7% | 64.8% | 55.8% | 55.9% |
Lung Cancer | 23.7% | 37.7% | 62.4% | 51.9% | 63.9% | 48.3% | 61.9% | 18.9% | 48.9% |
Breast Cancer | 5.3% | 39.2% | 37.6% | 48.4% | 67.4% | 72.8% | 43.8% | 40.4% | 42.9% |
Colorectal Cancer | 18.4% | 57.9% | 59.9% | 54.4% | 59.8% | 75.5% | 33.6% | 44.1% | 52.6% |
Pancreatic Cancer | 27.5% | 78.5% | 98.3% | 57.4% | 89.6% | 138.2% | 96.6% | 83.4% | 79.8% |
Oesophagus Cancer | 14.7% | 64.0% | 84.2% | 91.1% | 85.2% | 151.7% | 108.2% | 124.1% | 76.4% |
Stomach Cancer | 62.9% | 117.8% | 68.9% | 73.9% | 85.4% | 19.8% | 93.3% | 94.6% | 75.1% |
N-H Lymphoma | 10.5% | 35.3% | 41.4% | 44.6% | 53.2% | 70.4% | 111.3% | 49.5% | 45.4% |
Leukaemia | 6.4% | 46.8% | 43.0% | 30.2% | 48.0% | 109.8% | 49.9% | 176.6% | 45.9% |
Uterus Cancer | 11.0% | 66.2% | 42.6% | 67.5% | 75.7% | 68.8% | 0.0% | 83.1% | 52.3% |
Bladder Cancer | 10.9% | 19.3% | 60.1% | 61.7% | 53.6% | 49.8% | 70.5% | 118.6% | 46.7% |
Mental Behaviours Deaths | 6.7% | 0.0% | 4.8% | 4.1% | 4.5% | 6.2% | 22.4% | 107.0% | 7.1% |
Nervous System Deaths | 6.1% | 22.2% | 20.2% | 31.2% | 27.5% | 43.8% | 59.9% | 25.9% | 26.8% |
Circulatory Deaths | 25.7% | 31.7% | 31.0% | 31.9% | 32.8% | 26.7% | 41.2% | 38.6% | 31.1% |
Respiratory Deaths | 9.1% | 16.6% | 18.6% | 23.7% | 25.1% | 29.7% | 35.7% | 65.9% | 22.1% |
Digestive Deaths | 15.7% | 29.9% | 22.6% | 27.5% | 24.3% | 36.9% | 41.5% | 82.2% | 27.2% |